The procedureless Elipse intragastric balloon (EIGB) is a safe and effective alternative to surgery for weight loss and obesity, with minimal side effects, according to a study published in the Journal of Clinical Gastroenterology.

Seven studies were identified involving 2152 patients with a mean baseline body mass index ranging from 32.1 to 38.6 kg/m2. Patients were aged 18 to 65 years.

Read the full article at